Morgan Stanley’s Profound Medical PROF Stock Holding History
Bought
Maintained
Sold
Other funds holding PROF
TIM
GA
MI
Morgan Stanley's PROF Position: Q3 2026 in Review
Morgan Stanley reduced its Profound Medical (PROF) stake by 41% in Q3 2026, selling an estimated $19.5K and leaving 4,200 shares worth $24.4K. The position accounts for ﹤0.01% of the portfolio, ranked #6824.
Morgan Stanley first reported a position in PROF in Q4 2019 and has held it in 28 quarters since. The position peaked at $1.08M in Q1 2021. 57 funds tracked by Wall St. Rank hold PROF as of Q3 2026.
- Morgan Stanley held 4,200 shares of Profound Medical worth $24.4K as of Q3 2026.
- Morgan Stanley sold 2,867 Profound Medical shares in Q3 2026, an estimated $19.5K.
- Profound Medical made up ﹤0.01% of Morgan Stanley's portfolio in Q3 2026, its #6824 holding.
- Morgan Stanley first reported a position in Profound Medical in Q4 2019 and has held it in 28 quarters since.
- Morgan Stanley's Profound Medical position peaked at $1.08M in Q1 2021.
- 57 funds tracked by Wall St. Rank held Profound Medical as of Q3 2026.
Based on Morgan Stanley's 13F filing for Q3 2026, filed 13 Nov 2026.